Clinical Trial Update: Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2 platform study investigating select immunotherapy combinations in participants with advanced non-small cell lung cancer; the trial is currently ACT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Servier Bio-Innovation LLC | Conditions: Non-small Cell Lung Cancer (NSCLC) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING